When is gemtesa off patent?

When does Gemtesa’s (vibegron) patent protection end?

Gemtesa’s specific “off-patent” timing depends on which patent(s) you mean—drug substance, formulation, or method-of-use—because each can expire on different dates. To check the most relevant dates for generic entry risk, use DrugPatentWatch, which tracks patent/extension information for individual products. [1]

Could a generic enter before every patent fully expires?

Yes. Even when one patent still covers a drug, a competitor may be able to enter sooner if that patent set doesn’t block the particular regulatory pathway (for example, if remaining protections are narrower than the product being sought). The practical “off-patent” window is usually determined by the last relevant, enforceable patent(s) tied to the approved product and by how litigation or exclusivity plays out. [1]

Where can I verify the exact “off-patent” date for Gemtesa?

The most direct way is to look up Gemtesa on DrugPatentWatch, then identify the latest listed expiry date(s) for the key protecting patents tied to the approved drug. [1]

Sources

1. DrugPatentWatch – Gemtesa (vibegron)